| Old Articles: <Older 4211-4220 Newer> |
|---|
 |
The Motley Fool
November 1, 2004
Brian Gorman |
Bristol-Myers Stays the Course The pharma remains downbeat on its outlook through 2006, but two promising compounds could lift the company's fortunes.   |
The Motley Fool
November 1, 2004
Seth Jayson |
Beauty Takes a Beating Avon Products posts good numbers, but the stock smears. |
The Motley Fool
November 1, 2004
Rich Smith |
Defense Stock, Offensive Valuation Unfortunately for investors who do not already own the company, Raytheon's valuation already fully reflects this confluence of "good grades." Its stock currently sports a hefty 38 trailing P/E ratio. |
The Motley Fool
November 1, 2004
Rich Smith |
Buy the Dow The only discordant note in Dow Chemical's earnings report came from its cash-flow statement. The company's revenues for the quarter surpassed $10 billion, a 26% increase over Q3 2003. |
The Motley Fool
November 1, 2004
Rich Smith |
Supermarket on Sale But Archer Daniels Midland isn't likely to be undervalued for long. |
The Motley Fool
November 1, 2004
Dave Marino-Nachison |
K-Swiss Scores a Hit The "alternative" tennis shoe company appears to be on solid footing. Third-quarter sales rose 12% to $136 million, helped in large part by a nearly 56% rise in international business. |
The Motley Fool
November 1, 2004
Selena Maranjian |
Big Buybacks Some big companies are planning big buybacks, benefiting investors. IBM... Pfizer... etc. |
BusinessWeek
November 8, 2004
David Rocks |
Sony: A Bight Picture? Its electronics unit is back on its feet, with a slew of new products, but the real test comes at Christmas. |
BusinessWeek
November 8, 2004
Robert Barker |
Not Many Chinks in Symantec's Armor Demand for its Internet firewall and antivirus software programs is so strong that Symantec expects revenues in the fiscal year ending in March to surge 33%, its earnings per share jumping 44%, to $1.54. |
BusinessWeek
November 8, 2004
Gene G. Marcial |
Going "ka-Ching" at NCR A bright star in a bleak market, the company's shares bolted from 35 last December to 52 on Oct. 27. For six quarters, it posted happy earnings surprises as product demand kept on rising. Yet in spite of the stock's steep rise, some pros see room to run. |
| <Older 4211-4220 Newer> Return to current articles. |
